[
  {
    "title": "莎普爱思是个“筐”，“莆田系”都往里装",
    "href": "http://stock.jrj.com.cn/2023/01/05074837260085.shtml",
    "datetime": "2023-01-05 07:48:04",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：拟收购青岛视康100%股权",
    "href": "http://stock.jrj.com.cn/2023/01/03195737256419.shtml",
    "datetime": "2023-01-03 19:57:37",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：上海景兴以集中竞价减持37万股",
    "href": "http://stock.jrj.com.cn/2022/12/22154637231324.shtml",
    "datetime": "2022-12-22 15:46:28",
    "code": "603168"
  },
  {
    "title": "莎普爱思2名股东减持402.81万股 套现3448.54万 22年前三季度公司净利4525.84万",
    "href": "http://stock.jrj.com.cn/2022/12/21205137229550.shtml",
    "datetime": "2022-12-21 20:51:07",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：拟6000万元参投九颂堂远 其定投高峰医疗器械(无锡)",
    "href": "http://stock.jrj.com.cn/2022/12/07162337195091.shtml",
    "datetime": "2022-12-07 16:23:45",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：上海景兴累计减持1.79%股份",
    "href": "http://stock.jrj.com.cn/2022/11/29174437175021.shtml",
    "datetime": "2022-11-29 17:44:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东葛盛芳减持6万股 套现51.54万 2022年前三季度公司净利4526万",
    "href": "http://stock.jrj.com.cn/2022/11/11205337132762.shtml",
    "datetime": "2022-11-11 20:53:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：董事葛盛芳完成减持6万股",
    "href": "http://stock.jrj.com.cn/2022/11/11153737131198.shtml",
    "datetime": "2022-11-11 15:37:11",
    "code": "603168"
  },
  {
    "title": "莎普爱思大股东、董事频繁减持 “神药”事件后 业绩无起色",
    "href": "http://stock.jrj.com.cn/2022/09/23083037016190.shtml",
    "datetime": "2022-09-23 08:30:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：减持期过半 董事胡正国已减持11万股",
    "href": "http://stock.jrj.com.cn/2022/09/22161937014228.shtml",
    "datetime": "2022-09-22 16:19:53",
    "code": "603168"
  },
  {
    "title": "莎普爱思：公司股东及董事拟合计减持不超过651万股，占比近2.02%",
    "href": "http://stock.jrj.com.cn/2022/08/31193736959339.shtml",
    "datetime": "2022-08-31 19:37:49",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：上海景兴、葛盛芳拟减持合计不超2.02%股份",
    "href": "http://stock.jrj.com.cn/2022/08/31183936959083.shtml",
    "datetime": "2022-08-31 18:39:24",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：上半年净利润增32.19%至3563.21万元",
    "href": "http://stock.jrj.com.cn/2022/08/29224836949623.shtml",
    "datetime": "2022-08-29 22:48:38",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：上海景兴累计减持48万股",
    "href": "http://stock.jrj.com.cn/2022/05/30164536689873.shtml",
    "datetime": "2022-05-30 16:45:51",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：股东陈德康、董事胡正国拟合计减持不超1098.12万股",
    "href": "http://stock.jrj.com.cn/2022/05/27164136684900.shtml",
    "datetime": "2022-05-27 16:41:39",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：董事胡正国以集中竞价累计减持147万股",
    "href": "http://stock.jrj.com.cn/2022/05/09161736606831.shtml",
    "datetime": "2022-05-09 16:17:46",
    "code": "603168"
  },
  {
    "title": "莎普爱思2022年第一季度扣非净利润同比增长21.38％ “药+医”布局加持",
    "href": "http://stock.jrj.com.cn/2022/04/25193236466609.shtml",
    "datetime": "2022-04-25 19:32:05",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：一季度净利润增163.64%至2765.19万元",
    "href": "http://stock.jrj.com.cn/2022/04/25162036463858.shtml",
    "datetime": "2022-04-25 16:20:12",
    "code": "603168"
  },
  {
    "title": "莎普爱思：一季度净利同比增长163.64%",
    "href": "http://stock.jrj.com.cn/2022/04/25161036463770.shtml",
    "datetime": "2022-04-25 16:10:42",
    "code": "603168"
  },
  {
    "title": "莎普爱思2021年净利3565.61万同比扭亏为盈 董事长鄢标薪酬51.96万",
    "href": "http://stock.jrj.com.cn/2022/03/29165236147915.shtml",
    "datetime": "2022-03-29 16:52:53",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：2021年净利扭亏为盈至3565.61万元",
    "href": "http://stock.jrj.com.cn/2022/03/28200535927607.shtml",
    "datetime": "2022-03-28 20:05:04",
    "code": "603168"
  },
  {
    "title": "莎普爱思副总经理江建斌辞职 2021年公司净利3000万-4500万",
    "href": "http://stock.jrj.com.cn/2022/02/18193234395227.shtml",
    "datetime": "2022-02-18 19:32:40",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：持股6.65%股东上海景兴拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2022/02/06154134295509.shtml",
    "datetime": "2022-02-06 15:41:05",
    "code": "603168"
  },
  {
    "title": "莎普爱思2021年预计净利3000万-4500万 同比扭亏为盈 推进营销改革",
    "href": "http://stock.jrj.com.cn/2022/01/27213134234299.shtml",
    "datetime": "2022-01-27 21:31:47",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：2021年度预盈3000万元-4500万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2022/01/27182834231424.shtml",
    "datetime": "2022-01-27 18:28:20",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：减持数过半 董事胡正国已减持133.5万股",
    "href": "http://stock.jrj.com.cn/2022/01/17155434164758.shtml",
    "datetime": "2022-01-17 15:54:41",
    "code": "603168"
  },
  {
    "title": "【龙虎榜】莎普爱思1月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/14180834158525.shtml",
    "datetime": "2022-01-14 18:08:50",
    "code": "603168"
  },
  {
    "title": "【龙虎榜】莎普爱思1月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/11180834146932.shtml",
    "datetime": "2022-01-11 18:08:21",
    "code": "603168"
  },
  {
    "title": "莎普爱思董秘辞任：未取得董秘证的总经办主任黄明雄接任",
    "href": "http://stock.jrj.com.cn/2022/01/10171834141758.shtml",
    "datetime": "2022-01-10 17:18:50",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：获得头孢克肟颗粒的药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/01/07162234133682.shtml",
    "datetime": "2022-01-07 16:22:06",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东上海景兴减持28万股 套现284.57万 第三季度公司净利919.16万",
    "href": "http://stock.jrj.com.cn/2022/01/05183434124756.shtml",
    "datetime": "2022-01-05 18:34:33",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：非公开发行股票决议及授权有效期拟延期",
    "href": "http://stock.jrj.com.cn/2021/11/29153933937915.shtml",
    "datetime": "2021-11-29 15:39:21",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：非公开发行股票获证监会核准批文",
    "href": "http://stock.jrj.com.cn/2021/11/19155133880038.shtml",
    "datetime": "2021-11-19 15:51:22",
    "code": "603168"
  },
  {
    "title": "A股异动 | 莎普爱思(603168.SH)涨逾6% 非公开发行A股申请获审核通过",
    "href": "http://stock.jrj.com.cn/2021/11/09103233826475.shtml",
    "datetime": "2021-11-09 10:32:50",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：非公开发行A股申请获审核通过",
    "href": "http://stock.jrj.com.cn/2021/11/08185833824089.shtml",
    "datetime": "2021-11-08 18:58:51",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：第三季度净利增17.77%至919.16万元",
    "href": "http://stock.jrj.com.cn/2021/10/29195433779460.shtml",
    "datetime": "2021-10-29 19:54:23",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：董事胡正国拟减持不超267万股",
    "href": "http://stock.jrj.com.cn/2021/10/14162333691127.shtml",
    "datetime": "2021-10-14 16:23:30",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：上海景兴减持期过半 累计减持28万股",
    "href": "http://stock.jrj.com.cn/2021/10/08153833657493.shtml",
    "datetime": "2021-10-08 15:38:26",
    "code": "603168"
  },
  {
    "title": "莎普爱思2021年半年度净利2695.54万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/08/31125233360041.shtml",
    "datetime": "2021-08-31 12:52:48",
    "code": "603168"
  },
  {
    "title": "莎普爱思上半年成功扭亏 业绩“上蹿下跳”仍未改变",
    "href": "http://stock.jrj.com.cn/2021/08/31074933358618.shtml",
    "datetime": "2021-08-31 07:49:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：上半年净利约2695.54万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/08/30164033352627.shtml",
    "datetime": "2021-08-30 16:40:58",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：对外捐赠共计300万元支持防汛救灾",
    "href": "http://stock.jrj.com.cn/2021/07/22163333135509.shtml",
    "datetime": "2021-07-22 16:33:14",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：非公开发行股票申请获中证监受理",
    "href": "http://stock.jrj.com.cn/2021/07/19172933119779.shtml",
    "datetime": "2021-07-19 17:29:59",
    "code": "603168"
  },
  {
    "title": "【龙虎榜】莎普爱思6月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/06/24180732990661.shtml",
    "datetime": "2021-06-24 18:07:11",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：持股6.74%股东上海景兴拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2021/06/17170432948222.shtml",
    "datetime": "2021-06-17 17:04:16",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东上海景兴减持4万股 套现34.42万",
    "href": "http://stock.jrj.com.cn/2021/06/16204032946413.shtml",
    "datetime": "2021-06-16 20:40:09",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：上海景兴减持完毕 累计减持4万股",
    "href": "http://stock.jrj.com.cn/2021/06/16174232941320.shtml",
    "datetime": "2021-06-16 17:42:50",
    "code": "603168"
  },
  {
    "title": "【龙虎榜】莎普爱思5月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/25180632817370.shtml",
    "datetime": "2021-05-25 18:06:44",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：股东陈德康完成转让5.43%股份",
    "href": "http://stock.jrj.com.cn/2021/05/21155132793471.shtml",
    "datetime": "2021-05-21 15:51:36",
    "code": "603168"
  },
  {
    "title": "莎普爱思：泰州妇产医院设有包括生殖健康与不孕症专业在内的 20 余个医疗医技科室",
    "href": "http://stock.jrj.com.cn/2021/05/10153332729532.shtml",
    "datetime": "2021-05-10 15:33:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：泰州市妇产医院暂无辅助生殖中心",
    "href": "http://stock.jrj.com.cn/2021/05/10152832729425.shtml",
    "datetime": "2021-05-10 15:28:35",
    "code": "603168"
  },
  {
    "title": "莎普爱思：公司目前暂未参与医美行业",
    "href": "http://stock.jrj.com.cn/2021/05/10152732729424.shtml",
    "datetime": "2021-05-10 15:27:12",
    "code": "603168"
  },
  {
    "title": "【龙虎榜】莎普爱思4月29日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/04/29180932481021.shtml",
    "datetime": "2021-04-29 18:09:21",
    "code": "603168"
  },
  {
    "title": "归母净利润同比大幅上升2415.4％，莎普爱思一字涨停",
    "href": "http://stock.jrj.com.cn/2021/04/28101032469531.shtml",
    "datetime": "2021-04-28 10:10:09",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：一季度净利1048.84万元 同比增长2415.40%",
    "href": "http://stock.jrj.com.cn/2021/04/26172032454852.shtml",
    "datetime": "2021-04-26 17:20:14",
    "code": "603168"
  },
  {
    "title": "亏损1.79亿元！滴眼液黑料缠身，子公司打折甩卖！莎普爱思“弃药投医”行得通吗？",
    "href": "http://stock.jrj.com.cn/2021/04/21070632413782.shtml",
    "datetime": "2021-04-21 07:06:03",
    "code": "603168"
  },
  {
    "title": "莎普爱思2020年亏损1.79亿 董事长鄢标薪酬22.06万",
    "href": "http://stock.jrj.com.cn/2021/04/19234932404943.shtml",
    "datetime": "2021-04-19 23:49:09",
    "code": "603168"
  },
  {
    "title": "莎普爱思：公司目前暂未参与医美行业",
    "href": "http://stock.jrj.com.cn/2021/04/15164332380103.shtml",
    "datetime": "2021-04-15 16:43:44",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)拟将强身药业100%股权挂牌转让底价调整为8200万元",
    "href": "http://stock.jrj.com.cn/2021/03/24160832208804.shtml",
    "datetime": "2021-03-24 16:08:53",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：股东上海景兴减持期过半 累计减持4万股",
    "href": "http://stock.jrj.com.cn/2021/03/18211632159408.shtml",
    "datetime": "2021-03-18 21:16:52",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：强身药业100%股权挂牌期满 未征集到意向受让方",
    "href": "http://stock.jrj.com.cn/2021/02/18162431986890.shtml",
    "datetime": "2021-02-18 16:24:10",
    "code": "603168"
  },
  {
    "title": "莎普爱思2020年预计亏损1.36亿-1.7亿同比由盈转亏 滴眼液、大输液等产品销售收入下滑",
    "href": "http://stock.jrj.com.cn/2021/01/29212331811666.shtml",
    "datetime": "2021-01-29 21:23:11",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]莎普爱思连续第4次通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/01/21000031737475.shtml",
    "datetime": "2021-01-21 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2021/01/15161431698716.shtml",
    "datetime": "2021-01-15 16:14:01",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)拟再次挂牌转让强身药业100%股权",
    "href": "http://stock.jrj.com.cn/2021/01/11170931670892.shtml",
    "datetime": "2021-01-11 17:09:28",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东胡正国减持24万股 套现约210.6万元",
    "href": "http://stock.jrj.com.cn/2020/12/28191431587897.shtml",
    "datetime": "2020-12-28 19:14:04",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：董事胡正国减持期届满 累计减持24万股",
    "href": "http://stock.jrj.com.cn/2020/12/28163631586701.shtml",
    "datetime": "2020-12-28 16:36:55",
    "code": "603168"
  },
  {
    "title": "莎普爱思委身“莆田系”资本后",
    "href": "http://stock.jrj.com.cn/2020/12/28080431584018.shtml",
    "datetime": "2020-12-28 08:04:40",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)拟再次挂牌出售强身药业100%股权 挂牌底价1.37亿元",
    "href": "http://stock.jrj.com.cn/2020/12/21165931536964.shtml",
    "datetime": "2020-12-21 16:59:11",
    "code": "603168"
  },
  {
    "title": "莎普爱思“弃药投医”忙自救 “莆田系”新实控人包揽定增股份",
    "href": "http://stock.jrj.com.cn/2020/12/19063531522313.shtml",
    "datetime": "2020-12-19 06:35:59",
    "code": "603168"
  },
  {
    "title": "拟定增不超过6亿元 莎普爱思涨停",
    "href": "http://stock.jrj.com.cn/2020/12/18100131516454.shtml",
    "datetime": "2020-12-18 10:01:04",
    "code": "603168"
  },
  {
    "title": "A股异动 | 莎普爱思(603168.SH)涨停 拟定增募资最多6亿元",
    "href": "http://stock.jrj.com.cn/2020/12/18095931516385.shtml",
    "datetime": "2020-12-18 09:59:58",
    "code": "603168"
  },
  {
    "title": "莎普爱思前次募集资金使用 募集资金5.05亿元",
    "href": "http://stock.jrj.com.cn/invest/2020/12/18085331516879.shtml",
    "datetime": "2020-12-18 08:53:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思前次募集资金使用 募集资金5.05亿元",
    "href": "http://stock.jrj.com.cn/invest/2020/12/18085331538081.shtml",
    "datetime": "2020-12-18 08:53:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)拟定增募资不超6亿元 由控股股东养和投资及实控人之一林弘远认购",
    "href": "http://stock.jrj.com.cn/2020/12/17192031511293.shtml",
    "datetime": "2020-12-17 19:20:38",
    "code": "603168"
  },
  {
    "title": "“割肉”大甩卖曾5亿收购的子公司 经历“神药风波”的莎普爱思路在何方？",
    "href": "http://stock.jrj.com.cn/2020/12/14074531484002.shtml",
    "datetime": "2020-12-14 07:45:21",
    "code": "603168"
  },
  {
    "title": "莎普爱思获得政府补助119万元",
    "href": "http://stock.jrj.com.cn/invest/2020/12/11090731463399.shtml",
    "datetime": "2020-12-11 09:07:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思获得政府补助119万元",
    "href": "http://stock.jrj.com.cn/invest/2020/12/11090731538091.shtml",
    "datetime": "2020-12-11 09:07:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：公开挂牌转让强身药业100%股权 挂牌底价1.95亿元",
    "href": "http://stock.jrj.com.cn/2020/12/10182131457704.shtml",
    "datetime": "2020-12-10 18:21:58",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：累计获得与收益相关的政府补助款项共119.046万元",
    "href": "http://stock.jrj.com.cn/2020/12/10182131457705.shtml",
    "datetime": "2020-12-10 18:21:46",
    "code": "603168"
  },
  {
    "title": "莎普爱思挂牌出售强身药业获股东大会通过 深耕大健康初衷未变",
    "href": "http://stock.jrj.com.cn/2020/12/09193631450957.shtml",
    "datetime": "2020-12-09 19:36:24",
    "code": "603168"
  },
  {
    "title": "割肉亏损子公司 莎普爱思换帅做医院前景难料",
    "href": "http://stock.jrj.com.cn/2020/11/27071831357063.shtml",
    "datetime": "2020-11-27 07:18:01",
    "code": "603168"
  },
  {
    "title": "莆田系入主开出“扭亏药方”：莎普爱思“弃药从医”",
    "href": "http://stock.jrj.com.cn/2020/11/25192031347619.shtml",
    "datetime": "2020-11-25 19:20:18",
    "code": "603168"
  },
  {
    "title": "“神药”折戟，莎普爱思“弃药投医”自救？1.95亿元挂牌出售强身药业",
    "href": "http://stock.jrj.com.cn/2020/11/25075131343129.shtml",
    "datetime": "2020-11-25 07:51:45",
    "code": "603168"
  },
  {
    "title": "3亿收购强身药业布局中成药 如今终成莎普爱思“弃子”",
    "href": "http://stock.jrj.com.cn/2020/11/24001631334381.shtml",
    "datetime": "2020-11-24 00:16:35",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东上海景兴减持339.79万股 套现约2795.49万元",
    "href": "http://stock.jrj.com.cn/2020/11/23220531334201.shtml",
    "datetime": "2020-11-23 22:05:37",
    "code": "603168"
  },
  {
    "title": "洗脑“神药”或将停产 莎普爱思弃药投医自救",
    "href": "http://stock.jrj.com.cn/2020/11/03072131205358.shtml",
    "datetime": "2020-11-03 07:21:20",
    "code": "603168"
  },
  {
    "title": "莎普爱思“拳头”产品遭遇危机 生产经营或受重大影响",
    "href": "http://stock.jrj.com.cn/2020/11/01082231183010.shtml",
    "datetime": "2020-11-01 08:22:37",
    "code": "603168"
  },
  {
    "title": "莎普爱思前三季度亏损2805.65万由盈转亏 滴眼液、大输液产品销售收入下降",
    "href": "http://stock.jrj.com.cn/2020/10/29152131157689.shtml",
    "datetime": "2020-10-29 15:21:11",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/29024031153751.shtml",
    "datetime": "2020-10-29 02:40:01",
    "code": "603168"
  },
  {
    "title": "亏损2800万元 莎普爱思业绩持续承压",
    "href": "http://stock.jrj.com.cn/2020/10/29014031153659.shtml",
    "datetime": "2020-10-29 01:40:20",
    "code": "603168"
  },
  {
    "title": "莎普爱思：核心产品一致性评价工作存在无法按要求三年内完成的可能",
    "href": "http://stock.jrj.com.cn/2020/10/28184531151821.shtml",
    "datetime": "2020-10-28 18:45:31",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2020年第三次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/10/20001031086688.shtml",
    "datetime": "2020-10-20 00:10:47",
    "code": "603168"
  },
  {
    "title": "跌下神坛莎普爱思原股东套现离场 莆田系掌门人高溢价购旗下资产",
    "href": "http://stock.jrj.com.cn/2020/10/18174031075409.shtml",
    "datetime": "2020-10-18 17:40:37",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2020年第三次临时股东大会的延期公告",
    "href": "http://stock.jrj.com.cn/2020/10/13001031035281.shtml",
    "datetime": "2020-10-13 00:10:49",
    "code": "603168"
  },
  {
    "title": "莎普爱思(603168.SH)：就收购泰州医院100%股权收到监管问询函 要求对相关问题逐项作出书面说明",
    "href": "http://stock.jrj.com.cn/2020/10/12223231035042.shtml",
    "datetime": "2020-10-12 22:32:48",
    "code": "603168"
  },
  {
    "title": "神药风波未平超高溢价交易又起 “莆田系”做的什么莎普爱思",
    "href": "http://stock.jrj.com.cn/2020/10/12080231029205.shtml",
    "datetime": "2020-10-12 08:02:42",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2020年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/10/10001031013108.shtml",
    "datetime": "2020-10-10 00:10:31",
    "code": "603168"
  },
  {
    "title": "莎普爱思易主莆田系后获医疗资产注入 标的公司承诺未来三年至少盈利1.1亿",
    "href": "http://stock.jrj.com.cn/2020/10/09065331002107.shtml",
    "datetime": "2020-10-09 06:53:19",
    "code": "603168"
  },
  {
    "title": "莎普爱思：召开2020年第三次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/09/30001030862283.shtml",
    "datetime": "2020-09-30 00:10:27",
    "code": "603168"
  },
  {
    "title": "莎普爱思：第四届董事会第十四次会议（临时会议）决议公告",
    "href": "http://stock.jrj.com.cn/2020/09/30001030862284.shtml",
    "datetime": "2020-09-30 00:10:27",
    "code": "603168"
  },
  {
    "title": "莎普爱思“90后”老板开启资本运作 作价5亿拟将“莆田系”医院注入上市公司",
    "href": "http://stock.jrj.com.cn/2020/09/29234430862169.shtml",
    "datetime": "2020-09-29 23:44:40",
    "code": "603168"
  },
  {
    "title": "莎普爱思：拟现金收购泰州医院100%股权",
    "href": "http://stock.jrj.com.cn/2020/09/29223830861963.shtml",
    "datetime": "2020-09-29 22:38:47",
    "code": "603168"
  },
  {
    "title": "莎普爱思2020年上半年亏损1456.11万由盈转亏 营业收入同比下降",
    "href": "http://stock.jrj.com.cn/2020/08/20225030552135.shtml",
    "datetime": "2020-08-20 22:50:46",
    "code": "603168"
  },
  {
    "title": "莆田系接手 莎普爱思董事会大换血！“神药”风波余威犹存",
    "href": "http://stock.jrj.com.cn/2020/08/14064430495656.shtml",
    "datetime": "2020-08-14 06:44:11",
    "code": "603168"
  },
  {
    "title": "辞任光正集团副董事长 莆田系林春光要转战莎普爱思",
    "href": "http://stock.jrj.com.cn/2020/08/11071930470321.shtml",
    "datetime": "2020-08-11 07:19:48",
    "code": "603168"
  },
  {
    "title": "莎普爱思：实际业绩与预告业绩差幅达63% 被出具警示函",
    "href": "http://stock.jrj.com.cn/2020/08/07164430450592.shtml",
    "datetime": "2020-08-07 16:44:45",
    "code": "603168"
  },
  {
    "title": "莎普爱思证券事务代表、董秘办主任董丛杰辞职 因个人原因",
    "href": "http://stock.jrj.com.cn/2020/06/30212530100440.shtml",
    "datetime": "2020-06-30 21:25:57",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/06/05232029855977.shtml",
    "datetime": "2020-06-05 23:20:02",
    "code": "603168"
  },
  {
    "title": "莎普爱思实际控制人由陈德康变更为林弘立、林弘远兄弟",
    "href": "http://stock.jrj.com.cn/2020/05/29223429799035.shtml",
    "datetime": "2020-05-29 22:34:28",
    "code": "603168"
  },
  {
    "title": "莎普爱思：实际控制人由陈德康变更为林弘立、林弘远兄弟",
    "href": "http://stock.jrj.com.cn/2020/05/29214529798777.shtml",
    "datetime": "2020-05-29 21:45:32",
    "code": "603168"
  },
  {
    "title": "莎普爱思：股东上海景兴拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2020/05/05145729569113.shtml",
    "datetime": "2020-05-05 14:57:27",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东减持306.53万股 套现2741.79万元",
    "href": "http://stock.jrj.com.cn/2020/05/04133829531616.shtml",
    "datetime": "2020-05-04 13:38:32",
    "code": "603168"
  },
  {
    "title": "莎普爱思及下属公司2019年4月至2020年4收到政府补助合计631万元",
    "href": "http://stock.jrj.com.cn/2020/04/26102529376506.shtml",
    "datetime": "2020-04-26 10:25:32",
    "code": "603168"
  },
  {
    "title": "莎普爱思2020年一季度盈利41.70万减少98% 本期终端消费需求大幅减少",
    "href": "http://stock.jrj.com.cn/2020/04/25160629374607.shtml",
    "datetime": "2020-04-25 16:06:49",
    "code": "603168"
  },
  {
    "title": "莎普爱思2019年净利785.73万扭亏为盈 本期非经常性损益同比增加",
    "href": "http://stock.jrj.com.cn/2020/04/25151929374478.shtml",
    "datetime": "2020-04-25 15:19:12",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/25051029372005.shtml",
    "datetime": "2020-04-25 05:10:16",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/25051029372006.shtml",
    "datetime": "2020-04-25 05:10:16",
    "code": "603168"
  },
  {
    "title": "莎普爱思：第四届董事会第九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/25051029372003.shtml",
    "datetime": "2020-04-25 05:10:16",
    "code": "603168"
  },
  {
    "title": "莎普爱思：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/25051029372004.shtml",
    "datetime": "2020-04-25 05:10:16",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东养和投资质押2900万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2020/04/01200029170837.shtml",
    "datetime": "2020-04-01 20:00:59",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2019年净利786万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2020/04/01182329170308.shtml",
    "datetime": "2020-04-01 18:23:59",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2019年年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2020/04/01091029165740.shtml",
    "datetime": "2020-04-01 09:10:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：非公开发行限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2020/03/10000028983453.shtml",
    "datetime": "2020-03-10 00:00:26",
    "code": "603168"
  },
  {
    "title": "实控人或有变更 莎普爱思昔日拳头产品尚能饭否",
    "href": "http://stock.jrj.com.cn/2020/03/02075728929532.shtml",
    "datetime": "2020-03-02 07:57:21",
    "code": "603168"
  },
  {
    "title": "实控人套现10亿离场！90后“莆田系二代”或将接手“莎普爱思”",
    "href": "http://stock.jrj.com.cn/2020/02/28095628911834.shtml",
    "datetime": "2020-02-28 09:56:55",
    "code": "603168"
  },
  {
    "title": "莎普爱思卖身莆田系 19年预亏4000万",
    "href": "http://stock.jrj.com.cn/2020/02/28094728911777.shtml",
    "datetime": "2020-02-28 09:47:15",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]中国证监会投资者保护局温馨提示",
    "href": "http://stock.jrj.com.cn/2020/02/28000030427492.shtml",
    "datetime": "2020-02-28 00:00:00",
    "code": "603168"
  },
  {
    "title": "实控人或有变更 莎普爱思昔日拳头产品尚能饭否？",
    "href": "http://stock.jrj.com.cn/2020/02/27184328907945.shtml",
    "datetime": "2020-02-27 18:43:02",
    "code": "603168"
  },
  {
    "title": "莎普爱思将易主林氏兄弟陈德康有望两次套现8.124亿元",
    "href": "http://stock.jrj.com.cn/2020/02/27111028905571.shtml",
    "datetime": "2020-02-27 11:10:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思控制权拟发生变更 实控人将变更为林弘立、林弘远兄弟",
    "href": "http://stock.jrj.com.cn/2020/02/27074228903835.shtml",
    "datetime": "2020-02-27 07:42:48",
    "code": "603168"
  },
  {
    "title": "莎普爱思：大股东拟转让股权 控制权或发生变更",
    "href": "http://stock.jrj.com.cn/2020/02/26195128899239.shtml",
    "datetime": "2020-02-26 19:51:54",
    "code": "603168"
  },
  {
    "title": "莎普爱思：公司控制权拟发生变更",
    "href": "http://stock.jrj.com.cn/2020/02/26190628898735.shtml",
    "datetime": "2020-02-26 19:06:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]莎普爱思药业首批捐赠抗疫物资送达",
    "href": "http://stock.jrj.com.cn/2020/02/06000028787037.shtml",
    "datetime": "2020-02-06 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]【战“疫”】平湖经开莎普爱思药业提前恢复生产,保障大输液、头孢等药品供应",
    "href": "http://stock.jrj.com.cn/2020/01/31000028785209.shtml",
    "datetime": "2020-01-31 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/22100028718865.shtml",
    "datetime": "2020-01-22 10:00:11",
    "code": "603168"
  },
  {
    "title": "莎普爱思预扭亏新晋“莆田系”实控人能否带来新增长？",
    "href": "http://stock.jrj.com.cn/2020/01/22082828718452.shtml",
    "datetime": "2020-01-22 08:28:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2019年年度业绩预盈公告",
    "href": "http://stock.jrj.com.cn/2020/01/22002028715844.shtml",
    "datetime": "2020-01-22 00:20:11",
    "code": "603168"
  },
  {
    "title": "起底莆田系林家：吞下莎普爱思 右手眼科手术刀，左手白内障神药",
    "href": "http://stock.jrj.com.cn/2020/01/10075928655252.shtml",
    "datetime": "2020-01-10 07:59:55",
    "code": "603168"
  },
  {
    "title": "二股东将晋升成新东家 莎普爱思拟易主股价涨停",
    "href": "http://stock.jrj.com.cn/2020/01/09095428648063.shtml",
    "datetime": "2020-01-09 09:54:02",
    "code": "603168"
  },
  {
    "title": "莎普爱思拟易主 二股东将晋升成新东家",
    "href": "http://stock.jrj.com.cn/2020/01/08234328645911.shtml",
    "datetime": "2020-01-08 23:43:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：养和投资拟受让公司7.24%股份 将成控股股东",
    "href": "http://stock.jrj.com.cn/2020/01/08224228645801.shtml",
    "datetime": "2020-01-08 22:42:31",
    "code": "603168"
  },
  {
    "title": "莎普爱思2500万元业绩补偿款仍未着落 今年业绩扭亏难",
    "href": "http://stock.jrj.com.cn/2019/12/26085728588879.shtml",
    "datetime": "2019-12-26 08:57:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2019年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/19034028553618.shtml",
    "datetime": "2019-12-19 03:40:11",
    "code": "603168"
  },
  {
    "title": "莎普爱思：非公开发行限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2019/12/11000028515833.shtml",
    "datetime": "2019-12-11 00:00:23",
    "code": "603168"
  },
  {
    "title": "莎普爱思：关于召开2019年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/12/02233028480145.shtml",
    "datetime": "2019-12-02 23:30:01",
    "code": "603168"
  },
  {
    "title": "莎普爱思：第四届董事会第八次会议（临时会议）决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/02233028480144.shtml",
    "datetime": "2019-12-02 23:30:01",
    "code": "603168"
  },
  {
    "title": "莎普爱思：子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/12/02163428478168.shtml",
    "datetime": "2019-12-02 16:34:13",
    "code": "603168"
  },
  {
    "title": "莎普爱思：全资子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/12/02163128478192.shtml",
    "datetime": "2019-12-02 16:31:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思前三季度盈利3916万 同比下滑49.75%",
    "href": "http://stock.jrj.com.cn/2019/10/30084028323155.shtml",
    "datetime": "2019-10-30 08:40:03",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/30012028321229.shtml",
    "datetime": "2019-10-30 01:20:30",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]苄达赖氨酸滴眼液(莎普爱思)上市后临床试验研究者会议顺利召开",
    "href": "http://stock.jrj.com.cn/2019/10/16000028257505.shtml",
    "datetime": "2019-10-16 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思获得醋酸钠林格注射液药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/10/11211128235251.shtml",
    "datetime": "2019-10-11 21:11:18",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东上海景兴拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2019/10/11194128234891.shtml",
    "datetime": "2019-10-11 19:41:22",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东上海景兴拟减持股份 预计减持不超总股本2%",
    "href": "http://stock.jrj.com.cn/2019/10/11175728234064.shtml",
    "datetime": "2019-10-11 17:57:07",
    "code": "603168"
  },
  {
    "title": "莎普爱思：大股东上海景兴拟减持不超过645万股 占比2％",
    "href": "http://stock.jrj.com.cn/2019/10/11162028233442.shtml",
    "datetime": "2019-10-11 16:20:08",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]嘉兴市人大召开专题督办会议督办推动我司副总经理吴建伟提出的人大代表建议",
    "href": "http://stock.jrj.com.cn/2019/09/16000028133814.shtml",
    "datetime": "2019-09-16 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东上海景兴减持98万股 套现约742万元",
    "href": "http://stock.jrj.com.cn/2019/08/22112228015667.shtml",
    "datetime": "2019-08-22 11:22:18",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/16220027989930.shtml",
    "datetime": "2019-08-16 22:00:20",
    "code": "603168"
  },
  {
    "title": "莎普爱思：第四届董事会第六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/16220027989931.shtml",
    "datetime": "2019-08-16 22:00:20",
    "code": "603168"
  },
  {
    "title": "莎普爱思2019年上半年净利2,569.75万元 受品牌美誉度受损等因素影响",
    "href": "http://stock.jrj.com.cn/2019/08/16173927988473.shtml",
    "datetime": "2019-08-16 17:39:22",
    "code": "603168"
  },
  {
    "title": "莎普爱思：上半年净利2570万元 同比下降50%",
    "href": "http://stock.jrj.com.cn/2019/08/16161027987866.shtml",
    "datetime": "2019-08-16 16:10:56",
    "code": "603168"
  },
  {
    "title": "莎普爱思：上半年净利2570万元 同比降49.5%",
    "href": "http://stock.jrj.com.cn/2019/08/16160527987860.shtml",
    "datetime": "2019-08-16 16:05:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思以6000万自有资金认购理财产品 年化收益率为3.75%或4.15%",
    "href": "http://stock.jrj.com.cn/2019/08/14080027973224.shtml",
    "datetime": "2019-08-14 08:00:11",
    "code": "603168"
  },
  {
    "title": "莎普爱思4900万理财产品已到期收回 获46万理财收益",
    "href": "http://stock.jrj.com.cn/2019/08/09090127952113.shtml",
    "datetime": "2019-08-09 09:01:45",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]拼搏奉献,莎普爱思药业的知青印记",
    "href": "http://stock.jrj.com.cn/2019/07/24000027887421.shtml",
    "datetime": "2019-07-24 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思能否走出“神药”阴影",
    "href": "http://stock.jrj.com.cn/2019/07/09020827811643.shtml",
    "datetime": "2019-07-09 02:08:34",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]关注“年龄相关性白内障” 提升病程管理与保障水平",
    "href": "http://stock.jrj.com.cn/2019/07/02000027887420.shtml",
    "datetime": "2019-07-02 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东养和投资质押2180万股 公司去年净利较上年同期由盈转亏",
    "href": "http://stock.jrj.com.cn/2019/06/12074627692255.shtml",
    "datetime": "2019-06-12 07:46:31",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东上海景兴减持41万股 套现约318万元",
    "href": "http://stock.jrj.com.cn/2019/05/24072827617108.shtml",
    "datetime": "2019-05-24 07:28:30",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/05/22222027609064.shtml",
    "datetime": "2019-05-22 22:20:03",
    "code": "603168"
  },
  {
    "title": "业绩亏损转型遇挫 莎普爱思危机重重",
    "href": "http://stock.jrj.com.cn/2019/05/14044927566165.shtml",
    "datetime": "2019-05-14 04:49:40",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]开启乡村医生培训计划,莎普爱思药业助力精准医疗扶贫",
    "href": "http://stock.jrj.com.cn/2019/05/08000027625346.shtml",
    "datetime": "2019-05-08 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思虚假宣传风波后 一年狂卖7.5亿元的神药亏了",
    "href": "http://stock.jrj.com.cn/2019/05/07183227538431.shtml",
    "datetime": "2019-05-07 18:32:38",
    "code": "603168"
  },
  {
    "title": "虚假宣传风波一年后 曾经狂卖7.5亿的莎普爱思亏了",
    "href": "http://stock.jrj.com.cn/2019/05/07112627536638.shtml",
    "datetime": "2019-05-07 11:26:10",
    "code": "603168"
  },
  {
    "title": "莎普爱思一季度净利1944万元 同比下滑52% 现金流量净额为4626万元",
    "href": "http://stock.jrj.com.cn/2019/05/05074527522395.shtml",
    "datetime": "2019-05-05 07:45:05",
    "code": "603168"
  },
  {
    "title": "“神药”靠不住 莎普爱思靠什么",
    "href": "http://stock.jrj.com.cn/2019/04/30014827510101.shtml",
    "datetime": "2019-04-30 01:48:30",
    "code": "603168"
  },
  {
    "title": "莎普爱思去年净利1.26亿同比下滑186% 董事长陈德康薪酬为42万元",
    "href": "http://stock.jrj.com.cn/2019/04/29234527509927.shtml",
    "datetime": "2019-04-29 23:45:32",
    "code": "603168"
  },
  {
    "title": "上市公司晚间利空公告：莎普爱思2018年度由盈转亏1.26亿元",
    "href": "http://stock.jrj.com.cn/2019/04/26191527493048.shtml",
    "datetime": "2019-04-26 19:15:03",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年度由盈转亏1.26亿元",
    "href": "http://stock.jrj.com.cn/2019/04/26185227492901.shtml",
    "datetime": "2019-04-26 18:52:56",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年亏损1.26亿元 一季度业绩同比降逾五成",
    "href": "http://stock.jrj.com.cn/2019/04/26172427492168.shtml",
    "datetime": "2019-04-26 17:24:45",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年亏损1.26亿元 滴眼液营收下滑逾五成",
    "href": "http://stock.jrj.com.cn/2019/04/26170827492065.shtml",
    "datetime": "2019-04-26 17:08:00",
    "code": "603168"
  },
  {
    "title": "兴齐眼药12天11板走妖带火“眼睛概念股” 莎普爱思等涨停",
    "href": "http://stock.jrj.com.cn/2019/04/25110427480244.shtml",
    "datetime": "2019-04-25 11:04:56",
    "code": "603168"
  },
  {
    "title": "兴齐眼药8天7板带火“眼睛”概念股 莎普爱思、博士眼镜涨停",
    "href": "http://stock.jrj.com.cn/2019/04/19101327427410.shtml",
    "datetime": "2019-04-19 10:13:40",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]陈伟平:打造医药品牌 品质疗效是根本、全方位创新是引擎",
    "href": "http://stock.jrj.com.cn/2019/04/02000027308337.shtml",
    "datetime": "2019-04-02 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]传承千年的家书家训,能让我们汲取到什么力量",
    "href": "http://stock.jrj.com.cn/2019/03/11000027251145.shtml",
    "datetime": "2019-03-11 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/31020027005087.shtml",
    "datetime": "2019-01-31 02:00:13",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年年度业绩预亏公告",
    "href": "http://stock.jrj.com.cn/2019/01/31010127004927.shtml",
    "datetime": "2019-01-31 01:01:18",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]在寒冷的冬天,这家企业展现了不同的风采",
    "href": "http://stock.jrj.com.cn/2019/01/31000027251146.shtml",
    "datetime": "2019-01-31 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：股东拟减持不超过2%股份",
    "href": "http://stock.jrj.com.cn/2019/01/23173326947777.shtml",
    "datetime": "2019-01-23 17:33:38",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]回归传统文化,莎普爱思药业再启“家书家训”活动",
    "href": "http://stock.jrj.com.cn/2019/01/21000026936867.shtml",
    "datetime": "2019-01-21 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]莎普爱思药业获2018中国企业社会责任峰会扶贫奖",
    "href": "http://stock.jrj.com.cn/2019/01/21000026936866.shtml",
    "datetime": "2019-01-21 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思主业持续低谷 前3大股东上演逃跑式减持",
    "href": "http://stock.jrj.com.cn/2019/01/20080626929926.shtml",
    "datetime": "2019-01-20 08:06:42",
    "code": "603168"
  },
  {
    "title": "莎普爱思主业持续低谷 前三大股东上演逃跑式减持",
    "href": "http://stock.jrj.com.cn/2019/01/19093426927632.shtml",
    "datetime": "2019-01-19 09:34:33",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]关于因停电导致400电话暂停的情况说明",
    "href": "http://stock.jrj.com.cn/2019/01/16000026912379.shtml",
    "datetime": "2019-01-16 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：股东王泉平减持至持股5%以下 拟继续减持",
    "href": "http://stock.jrj.com.cn/2019/01/15180126907748.shtml",
    "datetime": "2019-01-15 18:01:13",
    "code": "603168"
  },
  {
    "title": "“神药风波”一年后 莎普爱思推新之路前途未卜",
    "href": "http://stock.jrj.com.cn/2019/01/14014626898350.shtml",
    "datetime": "2019-01-14 01:46:25",
    "code": "603168"
  },
  {
    "title": "控股股东溢价转让公司9.66%股份 莎普爱思涨停",
    "href": "http://stock.jrj.com.cn/2018/12/25095126798289.shtml",
    "datetime": "2018-12-25 09:51:31",
    "code": "603168"
  },
  {
    "title": "莎普爱思：控股股东溢价转让公司9.66%股份",
    "href": "http://stock.jrj.com.cn/2018/12/24212626795594.shtml",
    "datetime": "2018-12-24 21:26:01",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]“点睛中国——关注白内障中国行”在西安启动",
    "href": "http://stock.jrj.com.cn/2018/11/30000025427634.shtml",
    "datetime": "2018-11-30 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]莎普爱思药业披露一致性评价新进展,多名权威眼科专家建言建策",
    "href": "http://stock.jrj.com.cn/2018/10/25000025257497.shtml",
    "datetime": "2018-10-25 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]三季度研发投入增长3成,莎普爱思加大创新力度",
    "href": "http://stock.jrj.com.cn/2018/10/24000025253574.shtml",
    "datetime": "2018-10-24 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/22212025239463.shtml",
    "datetime": "2018-10-22 21:20:03",
    "code": "603168"
  },
  {
    "title": "莎普爱思：第四届董事会第三次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/09/25221025136621.shtml",
    "datetime": "2018-09-25 22:10:01",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/09/10235025071818.shtml",
    "datetime": "2018-09-10 23:50:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]莎普爱思药业40周年工作总结暨创新发展系列活动在浙江平湖举行",
    "href": "http://stock.jrj.com.cn/2018/09/05000025049415.shtml",
    "datetime": "2018-09-05 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]聚集的力量:莎普爱思药业的漫漫公益路",
    "href": "http://stock.jrj.com.cn/2018/09/03000025039812.shtml",
    "datetime": "2018-09-03 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]青少年近视率全球第一,莎普爱思药业产学研推动进军新市场的意向",
    "href": "http://stock.jrj.com.cn/2018/09/03000025039813.shtml",
    "datetime": "2018-09-03 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]公益,从来都不是“请客吃饭”!",
    "href": "http://stock.jrj.com.cn/2018/09/03000025039814.shtml",
    "datetime": "2018-09-03 00:00:00",
    "code": "603168"
  },
  {
    "title": "滴眼液卖不动了 莎普爱思开卖“壮阳药”",
    "href": "http://stock.jrj.com.cn/2018/08/27203425007247.shtml",
    "datetime": "2018-08-27 20:34:27",
    "code": "603168"
  },
  {
    "title": "莎普爱思：关于召开2018年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/08/24230124999166.shtml",
    "datetime": "2018-08-24 23:01:09",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/24230124999164.shtml",
    "datetime": "2018-08-24 23:01:08",
    "code": "603168"
  },
  {
    "title": "莎普爱思：第四届董事会第二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/08/24230124999165.shtml",
    "datetime": "2018-08-24 23:01:08",
    "code": "603168"
  },
  {
    "title": "莎普爱思：上半年净利同比减少43.86%",
    "href": "http://stock.jrj.com.cn/2018/08/24165124997510.shtml",
    "datetime": "2018-08-24 16:51:50",
    "code": "603168"
  },
  {
    "title": "莎普爱思：上半年净利同比降逾4成 滴眼液产品销售量同比大降",
    "href": "http://stock.jrj.com.cn/2018/08/24161024997262.shtml",
    "datetime": "2018-08-24 16:10:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思发布半年报 滴眼液产品销售量同比大幅下降",
    "href": "http://stock.jrj.com.cn/2018/08/24160724997249.shtml",
    "datetime": "2018-08-24 16:07:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]陈伟平:坚守质量第一 确保老百姓用药安全 努力践行社会责任",
    "href": "http://stock.jrj.com.cn/2018/07/11000025039811.shtml",
    "datetime": "2018-07-11 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：股东拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2018/06/27190524735790.shtml",
    "datetime": "2018-06-27 19:05:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东王泉平拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2018/06/27183924735670.shtml",
    "datetime": "2018-06-27 18:39:27",
    "code": "603168"
  },
  {
    "title": "普华制药拟“嫁”吉药控股 主营产品曾受莎普爱思牵连",
    "href": "http://stock.jrj.com.cn/2018/06/14001224677642.shtml",
    "datetime": "2018-06-14 00:12:02",
    "code": "603168"
  },
  {
    "title": "普华制药拟“嫁”吉药控股 主营产品曾受“莎普爱思风波”牵连",
    "href": "http://stock.jrj.com.cn/2018/06/13231824677534.shtml",
    "datetime": "2018-06-13 23:18:41",
    "code": "603168"
  },
  {
    "title": "莎普爱思：大股东上海景兴拟减持不超500万股",
    "href": "http://stock.jrj.com.cn/2018/06/13171124676212.shtml",
    "datetime": "2018-06-13 17:11:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：上海景兴拟减持不超1.55%股份",
    "href": "http://stock.jrj.com.cn/2018/06/13161024675778.shtml",
    "datetime": "2018-06-13 16:10:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]莎普爱思药业:陈德康40年莎药梦,一个方向一条心!",
    "href": "http://stock.jrj.com.cn/2018/06/06000024841901.shtml",
    "datetime": "2018-06-06 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]陈伟平:加大新药研发投入 降低单一产品依赖",
    "href": "http://stock.jrj.com.cn/2018/06/06000024827593.shtml",
    "datetime": "2018-06-06 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]【企业工匠】以坚韧、坚强、坚持的态度做好本职工作",
    "href": "http://stock.jrj.com.cn/2018/06/06000026838195.shtml",
    "datetime": "2018-06-06 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2017年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2018/05/31223024620900.shtml",
    "datetime": "2018-05-31 22:30:01",
    "code": "603168"
  },
  {
    "title": "莎普爱思年报推10转3派2元 股权登记6月7日",
    "href": "http://stock.jrj.com.cn/2018/05/31164924619395.shtml",
    "datetime": "2018-05-31 16:49:35",
    "code": "603168"
  },
  {
    "title": "[互动]莎普爱思：5月产品销售较4月有明显回升",
    "href": "http://stock.jrj.com.cn/2018/05/31152524618990.shtml",
    "datetime": "2018-05-31 15:25:43",
    "code": "603168"
  },
  {
    "title": "莎普爱思：4月份滴眼液销售大幅减少 5月已有明显回升",
    "href": "http://stock.jrj.com.cn/2018/05/30182524612767.shtml",
    "datetime": "2018-05-30 18:25:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：4月份滴眼液销售收入大幅减少 5月份同比明显回升",
    "href": "http://stock.jrj.com.cn/2018/05/30180624612762.shtml",
    "datetime": "2018-05-30 18:06:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：第四届董事会第一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/05/17230024555969.shtml",
    "datetime": "2018-05-17 23:00:19",
    "code": "603168"
  },
  {
    "title": "莎普爱思净利7年首现负值 神药事件损失至少1.2亿",
    "href": "http://stock.jrj.com.cn/2018/04/27075924461837.shtml",
    "datetime": "2018-04-27 07:59:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2017年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/26171024457410.shtml",
    "datetime": "2018-04-26 17:10:07",
    "code": "603168"
  },
  {
    "title": "莎普爱思：2018年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/26171024457411.shtml",
    "datetime": "2018-04-26 17:10:07",
    "code": "603168"
  },
  {
    "title": "莎普爱思：关于召开2017年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/04/26171024457409.shtml",
    "datetime": "2018-04-26 17:10:07",
    "code": "603168"
  },
  {
    "title": "莎普爱思：第三届董事会第十八次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/26171024457412.shtml",
    "datetime": "2018-04-26 17:10:07",
    "code": "603168"
  },
  {
    "title": "莎普爱思赔了商誉又折净利 去年广告风波损失1.2亿！",
    "href": "http://stock.jrj.com.cn/2018/04/26073624453432.shtml",
    "datetime": "2018-04-26 07:36:54",
    "code": "603168"
  },
  {
    "title": "\"滴眼液事件\"影响明显 莎普爱思年报、一季报业绩下滑",
    "href": "http://stock.jrj.com.cn/2018/04/25212824452001.shtml",
    "datetime": "2018-04-25 21:28:45",
    "code": "603168"
  },
  {
    "title": "莎普爱思年报净利下降47% 拟10转3派2元",
    "href": "http://stock.jrj.com.cn/2018/04/25181924451251.shtml",
    "datetime": "2018-04-25 18:19:20",
    "code": "603168"
  },
  {
    "title": "莎普爱思：年报净利降47% 拟10转3派2元",
    "href": "http://stock.jrj.com.cn/2018/04/25172024450760.shtml",
    "datetime": "2018-04-25 17:20:00",
    "code": "603168"
  },
  {
    "title": "765只个股连跌3日或3日以上 莎普爱思与雅百特跌三成",
    "href": "http://stock.jrj.com.cn/2017/12/24153723843220.shtml",
    "datetime": "2017-12-24 15:37:50",
    "code": "603168"
  },
  {
    "title": "莎普爱思股价4日跌28% 第二大股东补充质押600万股",
    "href": "http://stock.jrj.com.cn/2017/12/21171323832329.shtml",
    "datetime": "2017-12-21 17:13:20",
    "code": "603168"
  },
  {
    "title": "散户无视43页、近万字“陈情”公告 莎普爱思两跌停",
    "href": "http://stock.jrj.com.cn/2017/12/20070423820373.shtml",
    "datetime": "2017-12-20 07:04:39",
    "code": "603168"
  },
  {
    "title": "莎普爱思：实控人陈德康拟增1000到2000万元",
    "href": "http://stock.jrj.com.cn/2017/12/19192723818652.shtml",
    "datetime": "2017-12-19 19:27:58",
    "code": "603168"
  },
  {
    "title": "莎普爱思下架已审批广告 公司称尽力减少负面影响",
    "href": "http://stock.jrj.com.cn/2017/12/18000323805369.shtml",
    "datetime": "2017-12-18 00:03:05",
    "code": "603168"
  },
  {
    "title": "莎普爱思：公司广告符合药品广告审查发布的相关规定",
    "href": "http://stock.jrj.com.cn/2017/12/15214623800933.shtml",
    "datetime": "2017-12-15 21:46:29",
    "code": "603168"
  },
  {
    "title": "莎普爱思遭遇史上最大风波 被疑模糊消费者使用风险",
    "href": "http://stock.jrj.com.cn/2017/12/12160223780116.shtml",
    "datetime": "2017-12-12 16:02:00",
    "code": "603168"
  },
  {
    "title": "浙江证监局发函关注莎普爱思“广告门”",
    "href": "http://stock.jrj.com.cn/2017/12/08222123766132.shtml",
    "datetime": "2017-12-08 22:21:01",
    "code": "603168"
  },
  {
    "title": "上交所追问莎普爱思六事项：核实说明书和广告一致性",
    "href": "http://stock.jrj.com.cn/2017/12/08191923765465.shtml",
    "datetime": "2017-12-08 19:19:42",
    "code": "603168"
  },
  {
    "title": "莎普爱思将连续停牌 对相关事项进行核实",
    "href": "http://stock.jrj.com.cn/2017/12/08114323762918.shtml",
    "datetime": "2017-12-08 11:43:15",
    "code": "603168"
  },
  {
    "title": "莎普爱思连续停牌 对相关事项进行核实",
    "href": "http://stock.jrj.com.cn/2017/12/08013023759415.shtml",
    "datetime": "2017-12-08 01:30:30",
    "code": "603168"
  },
  {
    "title": "莎普爱思将连续停牌 对相关事项进行核实",
    "href": "http://stock.jrj.com.cn/2017/12/08005723759371.shtml",
    "datetime": "2017-12-08 00:57:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：关于公司股票连续停牌的提示性公告",
    "href": "http://stock.jrj.com.cn/2017/12/07221023759066.shtml",
    "datetime": "2017-12-07 22:10:08",
    "code": "603168"
  },
  {
    "title": "人民网评莎普爱思：对虚假医药广告就是要零容忍",
    "href": "http://stock.jrj.com.cn/2017/12/07205223758656.shtml",
    "datetime": "2017-12-07 20:52:46",
    "code": "603168"
  },
  {
    "title": "莎普爱思申请自12月8日起连续停牌",
    "href": "http://stock.jrj.com.cn/2017/12/07192623758369.shtml",
    "datetime": "2017-12-07 19:26:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：相关事项需要进一步核实 明起继续停牌",
    "href": "http://stock.jrj.com.cn/2017/12/07192023758330.shtml",
    "datetime": "2017-12-07 19:20:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：对公司目前情况进行初步评估 8日起停牌",
    "href": "http://stock.jrj.com.cn/2017/12/07191223758304.shtml",
    "datetime": "2017-12-07 19:12:18",
    "code": "603168"
  },
  {
    "title": "莎普爱思曾多次向浙江平湖科技局官员行贿 多人已领刑",
    "href": "http://stock.jrj.com.cn/2017/12/07183523758103.shtml",
    "datetime": "2017-12-07 18:35:09",
    "code": "603168"
  },
  {
    "title": "莎普爱思1年卖7.5亿的神药坑了老人 食药监总局发话",
    "href": "http://stock.jrj.com.cn/2017/12/07170323757416.shtml",
    "datetime": "2017-12-07 17:03:24",
    "code": "603168"
  },
  {
    "title": "畅销“神药”欺骗了中国老人？食药监总局发话了！",
    "href": "http://stock.jrj.com.cn/2017/12/07162723757107.shtml",
    "datetime": "2017-12-07 16:27:54",
    "code": "603168"
  },
  {
    "title": "浙江食药监局：已接到总局通知 正处理莎普爱思事宜",
    "href": "http://stock.jrj.com.cn/2017/12/07132123755753.shtml",
    "datetime": "2017-12-07 13:21:05",
    "code": "603168"
  },
  {
    "title": "5家公司临停 莎普爱思等重要事项未公告",
    "href": "http://stock.jrj.com.cn/2017/12/07090923754302.shtml",
    "datetime": "2017-12-07 09:09:18",
    "code": "603168"
  },
  {
    "title": "五公司今日开市起停牌 莎普爱思昨日遭食药监局通报",
    "href": "http://stock.jrj.com.cn/2017/12/07090823754244.shtml",
    "datetime": "2017-12-07 09:08:26",
    "code": "603168"
  },
  {
    "title": "食药监总局要求尽快启动临床有效性试验 莎普爱思：严格按照要求重新评价",
    "href": "http://stock.jrj.com.cn/2017/12/06204523752175.shtml",
    "datetime": "2017-12-06 20:45:35",
    "code": "603168"
  },
  {
    "title": "国家食药监总局：要求督促莎普爱思尽快启动临床有效性试验",
    "href": "http://stock.jrj.com.cn/2017/12/06191023751848.shtml",
    "datetime": "2017-12-06 19:10:00",
    "code": "603168"
  },
  {
    "title": "食药监:要求浙江食药监局督促莎普爱思启动有效性试验",
    "href": "http://stock.jrj.com.cn/2017/12/06185923751767.shtml",
    "datetime": "2017-12-06 18:59:23",
    "code": "603168"
  },
  {
    "title": "从1.45元到59.8元 莎普爱思经历了什么？",
    "href": "http://stock.jrj.com.cn/2017/12/06175523751380.shtml",
    "datetime": "2017-12-06 17:55:41",
    "code": "603168"
  },
  {
    "title": "莎普爱思质疑者崔红平资本图谱曝光:包括高瓴资本",
    "href": "http://stock.jrj.com.cn/2017/12/06173923751298.shtml",
    "datetime": "2017-12-06 17:39:28",
    "code": "603168"
  },
  {
    "title": "散户无视澄清公告连续撤退莎普爱思",
    "href": "http://stock.jrj.com.cn/2017/12/06070723747031.shtml",
    "datetime": "2017-12-06 07:07:08",
    "code": "603168"
  },
  {
    "title": "莎普爱思毛利超茅台被质疑 据实举报or同行“眼红”",
    "href": "http://stock.jrj.com.cn/2017/12/05190823745150.shtml",
    "datetime": "2017-12-05 19:08:54",
    "code": "603168"
  },
  {
    "title": "浙江食品药品稽查局回应：未发现莎普爱思滴眼液抽验不合格",
    "href": "http://stock.jrj.com.cn/2017/12/05173523744635.shtml",
    "datetime": "2017-12-05 17:35:00",
    "code": "603168"
  },
  {
    "title": "浙江省食品药品稽查局：未发现莎普爱思滴眼液抽验不合格",
    "href": "http://stock.jrj.com.cn/2017/12/05152523743324.shtml",
    "datetime": "2017-12-05 15:25:00",
    "code": "603168"
  },
  {
    "title": "浙江省食品药品稽查局：未发现莎普爱思滴眼液不合格",
    "href": "http://stock.jrj.com.cn/2017/12/05150023743193.shtml",
    "datetime": "2017-12-05 15:00:24",
    "code": "603168"
  },
  {
    "title": "骂声中莎普爱思销量9年涨41倍 独门眼药撑起上市公司",
    "href": "http://stock.jrj.com.cn/2017/12/05101523741435.shtml",
    "datetime": "2017-12-05 10:15:46",
    "code": "603168"
  },
  {
    "title": "关于莎普爱思早盘的跌停，“丁香医生”说的营销与治病孰是孰非？",
    "href": "http://stock.jrj.com.cn/2017/12/04224223739316.shtml",
    "datetime": "2017-12-04 22:42:30",
    "code": "603168"
  },
  {
    "title": "毛利润率高达94.59% 莎普爱思惊天暴利从何而来？",
    "href": "http://stock.jrj.com.cn/2017/12/04211223738984.shtml",
    "datetime": "2017-12-04 21:12:50",
    "code": "603168"
  },
  {
    "title": "莎普爱思卖眼药水年赚7亿 眼科专家有话说…",
    "href": "http://stock.jrj.com.cn/2017/12/04211123738976.shtml",
    "datetime": "2017-12-04 21:11:39",
    "code": "603168"
  },
  {
    "title": "毛利润率高达94.59% 莎普爱思惊天暴利从何而来？",
    "href": "http://stock.jrj.com.cn/2017/12/04205223738921.shtml",
    "datetime": "2017-12-04 20:52:24",
    "code": "603168"
  },
  {
    "title": "莎普爱思遭炮轰:\"模糊滴、重影滴…\" 股价也\"低\"了…",
    "href": "http://stock.jrj.com.cn/2017/12/04163623737854.shtml",
    "datetime": "2017-12-04 16:36:48",
    "code": "603168"
  },
  {
    "title": "莎普爱思股价节节走低 国民信托重仓恐亏损惨重",
    "href": "http://stock.jrj.com.cn/2017/12/04113723735976.shtml",
    "datetime": "2017-12-04 11:37:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思大跌7% 旗下滴眼液被质疑",
    "href": "http://stock.jrj.com.cn/2017/12/04100023735270.shtml",
    "datetime": "2017-12-04 10:00:00",
    "code": "603168"
  },
  {
    "title": "快讯：莎普爱思受负消息面影响 股价大跌逾6%",
    "href": "http://stock.jrj.com.cn/2017/12/04094823735159.shtml",
    "datetime": "2017-12-04 09:48:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思一度跌停 昨晚澄清媒体质疑",
    "href": "http://stock.jrj.com.cn/2017/12/04093823735123.shtml",
    "datetime": "2017-12-04 09:38:06",
    "code": "603168"
  },
  {
    "title": "莎普爱思遭眼科医生声讨 股价跌停",
    "href": "http://stock.jrj.com.cn/2017/12/04093723735070.shtml",
    "datetime": "2017-12-04 09:37:32",
    "code": "603168"
  },
  {
    "title": "莎普爱思遭眼科医生声讨 股价暴跌9.24%",
    "href": "http://stock.jrj.com.cn/2017/12/04092923734998.shtml",
    "datetime": "2017-12-04 09:29:49",
    "code": "603168"
  },
  {
    "title": "莎普爱思称产品效果安全有效 专家呼吁重新临床试验",
    "href": "http://stock.jrj.com.cn/2017/12/04010423733223.shtml",
    "datetime": "2017-12-04 01:04:20",
    "code": "603168"
  },
  {
    "title": "莎普爱思回应称滴眼液效果安全有效 眼科专家呼吁重新进行临床试验",
    "href": "http://stock.jrj.com.cn/2017/12/04001423733149.shtml",
    "datetime": "2017-12-04 00:14:52",
    "code": "603168"
  },
  {
    "title": "莎普爱思澄清误报：公司滴眼液产品安全有效",
    "href": "http://stock.jrj.com.cn/2017/12/03210423732932.shtml",
    "datetime": "2017-12-03 21:04:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思澄清：滴眼液是安全、有效的抗白内障药物",
    "href": "http://stock.jrj.com.cn/2017/12/03201623732795.shtml",
    "datetime": "2017-12-03 20:16:00",
    "code": "603168"
  },
  {
    "title": "洗脑神药莎普爱思遭眼科医生声讨：一年狂卖7.5亿元",
    "href": "http://stock.jrj.com.cn/2017/12/03194823732743.shtml",
    "datetime": "2017-12-03 19:48:47",
    "code": "603168"
  },
  {
    "title": "莎普爱思澄清\"洗脑神药\"传言：为安全有效的抗白内障药物",
    "href": "http://stock.jrj.com.cn/2017/12/03192823732704.shtml",
    "datetime": "2017-12-03 19:28:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：公司滴眼液是安全的、有效的抗白内障药物",
    "href": "http://stock.jrj.com.cn/2017/12/03185623732652.shtml",
    "datetime": "2017-12-03 18:56:36",
    "code": "603168"
  },
  {
    "title": "莎普爱思：公司滴眼液是一种安全的、有效的抗白内障药物",
    "href": "http://stock.jrj.com.cn/2017/12/03185523732650.shtml",
    "datetime": "2017-12-03 18:55:00",
    "code": "603168"
  },
  {
    "title": "洗脑神药莎普爱思:一年狂卖7.5亿 研发费仅0.29亿",
    "href": "http://stock.jrj.com.cn/2017/12/03121923732109.shtml",
    "datetime": "2017-12-03 12:19:02",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]莎普爱思党支部、工会举办“健康之路伴你行” 健步走公益活动",
    "href": "http://stock.jrj.com.cn/2017/08/25000023092104.shtml",
    "datetime": "2017-08-25 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思：首次公开发行限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2017/06/26221022658075.shtml",
    "datetime": "2017-06-26 22:10:08",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]公司及子公司喜获2016年度平湖经济技术开发区部分荣誉",
    "href": "http://stock.jrj.com.cn/2017/03/13000024374254.shtml",
    "datetime": "2017-03-13 00:00:00",
    "code": "603168"
  },
  {
    "title": "[莎普爱思]莎普爱思工会在元宵节为员工送去福利",
    "href": "http://stock.jrj.com.cn/2017/02/10000023092105.shtml",
    "datetime": "2017-02-10 00:00:00",
    "code": "603168"
  },
  {
    "title": "莎普爱思股东上海景兴完成500万股减持计划",
    "href": "http://stock.jrj.com.cn/2016/02/23174620597135.shtml",
    "datetime": "2016-02-23 17:46:21",
    "code": "603168"
  }
]